← All investors
Dynamk Capital
About
Dynamk Capital is a New York venture firm investing in life science industrials: the tools, technologies and services that support drug discovery, development and manufacturing. Its first fund closed at $65m with backers including Pfizer Ventures. Portfolio companies include RoosterBio, Curi Bio and Envisagenics.
Stage focus
Pre-SeedSeedSeries A
Raising from Dynamk Capital?
I've worked with founders across the industrial stack. If Dynamk Capital is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan